NCT06526481Completed
Nasoseptal Double Flap Versus Rescue Flap in Endoscopic Transsphenoidal Pituitary Surgery
Source: ClinicalTrials.gov · Last updated 12 Aug 2024
Brief summary (registry, in English)
This paper investigates the outcomes of two surgical techniques-nasoseptal double flap and nasoseptal rescue flap-used in endoscopic transsphenoidal surgery for pituitary tumors. The nasoseptal flap technique has significantly reduced the incidence of postoperative Cerebrospinal Fluid (CSF) leaks but can cause nasal morbidity.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 18 Jul 2024
- Start date
- 12 Dec 2022
- Primary completion date
- 26 Mar 2024
- Lead sponsor
- Mansoura University
- NCT number
- NCT06526481
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From 12 Dec 2022 to the primary completion date, 26 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recurrent pituitary tumor after previous surgery.
- Previous nasal surgery.
- Refusal of surgical intervention or signing consent.
Other illness
- Associated nasal disease e.g. rhinosinusitis.
Other
- -Absent sphenoid pneumatization.
- Temporal or frontal extension.
- Unfit for general anesthesia.
Who the study is looking for
- All consecutive patients with symptomatic pituitary macroadenoma
- Tumor size ≥ 2 cm
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mansoura University, Department of otorhinolaryngology Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.